BTIG Research reiterated their hold rating on shares of Intuitive Surgical (NASDAQ:ISRG) in a research note published on Monday morning, AnalystRatings.com reports.
A number of other brokerages also recently commented on ISRG. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $600.00 to $700.00 and gave the company an overweight rating in a report on Wednesday, July 22nd. Robert W. Baird assumed coverage on Intuitive Surgical in a report on Tuesday, September 1st. They set a neutral rating and a $700.00 target price for the company. Deutsche Bank upped their price target on Intuitive Surgical from $500.00 to $600.00 and gave the stock a hold rating in a research note on Wednesday, July 22nd. OTR Global cut Intuitive Surgical to a positive rating in a research note on Tuesday, June 16th. Finally, Wells Fargo & Company upped their price target on Intuitive Surgical from $632.00 to $727.00 and gave the stock an overweight rating in a research note on Wednesday, July 22nd. Three analysts have rated the stock with a sell rating, ten have issued a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. The stock has an average rating of Hold and a consensus price target of $680.52.
NASDAQ ISRG opened at $691.39 on Monday. Intuitive Surgical has a 1 year low of $360.50 and a 1 year high of $778.83. The stock has a market capitalization of $80.91 billion, a PE ratio of 72.70, a PEG ratio of 12.33 and a beta of 0.97. The business’s 50-day moving average is $702.42 and its 200 day moving average is $581.40.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 21st. The medical equipment provider reported $1.11 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.59 by $0.52. The firm had revenue of $852.10 million for the quarter, compared to analyst estimates of $675.15 million. Intuitive Surgical had a return on equity of 13.62% and a net margin of 26.07%. During the same period last year, the company earned $3.25 EPS. As a group, equities analysts anticipate that Intuitive Surgical will post 7.09 EPS for the current year.
In related news, Director Alan J. Levy sold 1,800 shares of the firm’s stock in a transaction that occurred on Tuesday, July 21st. The shares were sold at an average price of $670.71, for a total transaction of $1,207,278.00. Also, VP Robert Desantis sold 1,798 shares of the firm’s stock in a transaction that occurred on Friday, July 24th. The stock was sold at an average price of $666.21, for a total transaction of $1,197,845.58. Following the sale, the vice president now owns 3,348 shares of the company’s stock, valued at $2,230,471.08. The disclosure for this sale can be found here. Insiders sold 29,880 shares of company stock valued at $20,504,788 over the last quarter. Insiders own 1.60% of the company’s stock.
Large investors have recently modified their holdings of the stock. Wellington Management Group LLP increased its stake in shares of Intuitive Surgical by 428.9% in the 1st quarter. Wellington Management Group LLP now owns 1,433,496 shares of the medical equipment provider’s stock valued at $709,882,000 after acquiring an additional 1,162,469 shares during the last quarter. Capital World Investors increased its position in shares of Intuitive Surgical by 13.5% during the first quarter. Capital World Investors now owns 4,969,285 shares of the medical equipment provider’s stock worth $2,460,849,000 after buying an additional 591,816 shares during the period. Sustainable Growth Advisers LP acquired a new stake in shares of Intuitive Surgical during the first quarter worth $236,924,000. Fisher Asset Management LLC increased its position in shares of Intuitive Surgical by 59.5% during the second quarter. Fisher Asset Management LLC now owns 1,127,342 shares of the medical equipment provider’s stock worth $642,393,000 after buying an additional 420,411 shares during the period. Finally, BlackRock Inc. increased its position in shares of Intuitive Surgical by 4.7% during the second quarter. BlackRock Inc. now owns 9,339,239 shares of the medical equipment provider’s stock worth $5,321,778,000 after buying an additional 415,788 shares during the period. Hedge funds and other institutional investors own 86.94% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Story: Elliott Wave Theory
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.